Find your next paid study

Wake Forest University Health SciencesNCT05825066

Actual pay is set by the research site.

Phase 1

Intraperitoneal Paclitaxel With Standard Systemic NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis: Prospective Pilot Trial

This goal of this clinical trial is to learn whether the drug combination of intraperitoneal paclitaxel (chemotherapy given directly into the abdominal cavity)…

Pancreatic Ductal Adenocarcinoma (PDAC)

University of Colorado, DenverNCT07030283

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and chang…

Hepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more

CancerFatigueBrain Tumor Adult

~$150 – $4,500

Actual pay is set by the research site.

AbbVieNCT06084481

Observational

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer surviv…

M.D. Anderson Cancer CenterNCT07186556

~$10 – $750

Actual pay is set by the research site.

Registry of Myriad™ Utilization in Soft Tissue Reconstruction Procedures

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll…

Abdominal Wound DehiscenceNecrotizing Soft Tissue InfectionLower Extremity Wound+4 more

Aroa Biosurgery LimitedNCT05243966

~$10 – $1,050

Actual pay is set by the research site.

High Grade Neuroendocrine Neoplasms

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)

The investigators hypothesize that zanzalintinib maintenance therapy after initial cytotoxic chemotherapy can prolong the progression-free survival (PFS) in pa…

Washington University School of MedicineNCT06926634

Actual pay is set by the research site.

Observational

A Real-World, Single-Arm Observational Study Evaluating the Effects of MyVitalC (ESS60 in Extra Virgin Olive Oil) on Sleep Disturbance and Everyday Headaches

Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a comm…

SleepHeadaches

~$10 – $1,050

Actual pay is set by the research site.

Efforia, IncNCT07477236

Phase 1

A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients With Advanced Solid Tumors

The goal of this clinical trial is to define a safe and effective dose of CRB-701 for participants with solid tumors that are expressing a protein called necti…

Solid Tumor, Adult

Corbus Pharmaceuticals Inc.NCT06265727

~$150 – $4,200

Actual pay is set by the research site.

Adamantinous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Phase 2 Study of the MEK Inhibitor MEKTOVI® (Binimetinib) for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

MEKTOVI (binimetinib) is an oral, highly selective reversible inhibitor of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. The biolo…

Nationwide Children's HospitalNCT05286788

Actual pay is set by the research site.

Phase 3

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is r…

Childhood Extracranial Germ Cell TumorExtragonadal Embryonal CarcinomaGerm Cell Tumor+27 more

Squamous Cell Carcinoma of Head and NeckSinus CancerNasal Cavity Cancer+9 more

A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy

The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with r…

Memorial Sloan Kettering Cancer CenterNCT07063212

Actual pay is set by the research site.

GlioblastomaBrain CancerGlioblastoma Multiforme+4 more

Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma.

The purpose of this research is to test the safety and effectiveness of the investigational drug ruxolitinib when it is combined with standard of care treatmen…